How much funding has C the Signs raised?

C the Signs has raised $13.0M in total funding, most recently a Series B round.

Who are C the Signs's investors?

C the Signs's investors include Khosla Ventures, MMC Ventures, Ataraxia, Acequia Capital.

When was C the Signs founded?

C the Signs was founded in 2017.

Where is C the Signs headquartered?

C the Signs is headquartered in London, United Kingdom.

What industry is C the Signs in?

C the Signs operates in Artificial Intelligence, Healthcare.

C the Signs

London, United Kingdom · Founded 2017 · $13.0M raised

Artificial Intelligence

Healthcare

Headquarters: London
Founded: 2017
Business Model: B2B
Website: cthesigns.com

Total Funding: $13.0M
Last Round: $8.0M Series BJan 2025
Rounds: 2

About

C the Signs is an AI-powered clinical decision-support platform, incorporated in London in March 2017 by NHS doctors Dr Bea Bakshi and Dr Miles Payling, that helps healthcare professionals identify patients at risk of cancer earlier using real-time data and evidence-based pathways. The MHRA Class I medical device integrates with NHS systems such as EMIS and SystmOne and analyzes over 1,000 clinical datapoints across 100+ cancer types to support earlier referral and diagnosis.

Summary

C the Signs is an Artificial Intelligence company based in London, United Kingdom, founded in 2017. It has raised $13.0M in total across 2 rounds, most recently a $8.0M Series B round in Jan 2025. Investors include Khosla Ventures, MMC Ventures and Ataraxia.